S1PR3 and hepatocellular carcinoma: Contrary to the modulation of the SPL expression levels in human HCC and colorectal cancer, we observed no significant modulation of the SPL levels in esophageal cancer, which showed only enhanced expression levels of the S1P2, S1P3 and S1P5 receptors (Figure S2A).